A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome

Epilepsia

Volumn 52, Issue 1, 2011, Pages 175-178

  Tro Baumann, Blanca ^a   Von Spiczak, Sarah ^b,c   Lotte, Jan ^a   Bast, Thomas ^d   Haberlandt, Edda ^e   Sassen, Robert ^f   Freund, Alfred ^g   Leiz, Steffen ^h   Stephani, Ulrich ^b,c   Boor, Rainer ^c   Holthausen, Hans ^a   Helbig, Ingo ^b   Kluger, Gerhard ^a  

^a Department of Neuropediatrics   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Northern German Epilepsy Center for Children and Adolescents   (Germany)

^d Epilepsy Center Kork   (Germany)

^e UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^f UNIVERSITY HOSPITAL BONN   (Germany)

^g SANA KLINIKUM OFFENBACH   (Germany)

^h Klinikum Dritter Orden   (Germany)

Author keywords

Dravet; Fever; SCN1A; Seizure; Severe myoclonic epilepsy of infancy; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; SODIUM CHANNEL NAV1.1;

ADOLESCENT; ADULT; ARTICLE; CHILD; EPILEPTIC STATE; FEVER; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; EPILEPSIES, MYOCLONIC; HUMANS; INCIDENCE; INFANT; MUTATION; NERVE TISSUE PROTEINS; RETROSPECTIVE STUDIES; SEIZURES; SODIUM CHANNELS; SYNDROME; VACCINATION; YOUNG ADULT;

EID: 78651325927     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02885.x     Document Type: Article

References (15)

1. Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N,; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group. (2001) The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med 345: 656-661.
2. Berkovic SF, Harkin L, McMahon JM, Pelekanos JT, Zuberi SM, Wirrell EC, Gill DS, Iona X, Mulley JC, Scheffer IE,. (2006) De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 5: 488-492.
3. Caraballo RH, Fejermann N,. (2006) Dravet syndrome: a study of 53 patients. Epilepsy Res 70: S231-S238.
4. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P,. (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68: 1327-1332.
5. Depienne C, Trouillard O, Saint-Martin C, Gourfinkel-An I, Bouteiller D, Carpentier W, Keren B, Abert B, Gautier A, Baulac S, Arzimanoglou A, Cazeneuve C, Nabbout R, LeGuern E,. (2009) Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet 46: 183-191.
6. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O,. (2005) Severe myoclonic epilepsy in infancy (Dravet syndrome). In, Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, (Eds) Epileptic syndromes in infancy, childhood and adolescence. John Libbey Eurotext Ltd, Montrogue, pp. 77-88.
7. Farrington P, Pugh S, Colville A, Flower A, Nash J, Morgan-Capner P, Rush M, Miller E,. (1995) A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 345: 567-569.
8. Lux AL,. (2010) Treatment of febrile seizures: historical perspective, current opinions, and potential future directions. Brain Dev 32: 42-50.
9. McIntosh AM, McMahon J, Dibbens LM, Iona X, Mulley JC, Scheffer IE, Berkovic SF,. (2010) Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study. Lancet Neurol 9: 592-598.
10. Mulley JC, Nelson P, Guerrero S, Dibbens L, Iona X, McMahon JM, Harkin L, Schouten J, Yu S, Berkovic SF, Scheffer IE,. (2006) A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A. Neurology 67: 1094-1095.
11. Nabbout R, Gennaro E, Dalla Bernardina B, Dulac O, Madia F, Bertini E, Capovilla G, Chiron C, Cristofori G, Elia M, Fontana E, Gaggero R, Granata T, Guerrini R, Loi M, La Selva L, Lispi ML, Matricardi A, Romeo A, Tzolas V, Valseriati D, Veggiotti P, Vigevano F, Vallee L, Dagna Bricarelli F, Bianchi A, Zara F,. (2003) Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 60: 1961-1967. (Pubitemid 36736013)
12. Nieto-Barrera M, Lillo MM, Rodríguez-Collado C, Candau R, Correra A,. (2000) [Severe myoclonic epilepsy in childhood. Epidemiologoc analytical study]. Rev Neurol 30: 620-624.
13. Stephenson JBP,. (1991) Epilepsy Curr Opin Neurol Neurosurg 4: 406-409.
14. Strengell T, Uhari M, Tarkka R, Uusimaa J, Alen R, Lautala P, Rantala H,. (2009) Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch Pediatr Adolesc Med 163: 799-804.
15. Tanabe T, Awaya Y, Matsuishi T, Iyoda K, Nagai T, Kurihara M, Yamamoto K, Minagawa K, Maekawa K,. (2008) Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome) - a nationwide questionnaire survey in Japan. Brain Dev 30: 629-635.